Quick Answer
Zivo Bioscience, Inc. reported Diluted EPS of $4.23 per share (loss) for fiscal year 2024.
Zivo Bioscience, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$4.23 | +8.0% |
| 2023 | -$4.60 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.27 | +59.7% | +37.2% |
| June 30, 2025 | -$0.43 | +84.5% | +61.6% |
| March 31, 2025 | -$1.12 | -138.3% | -67.2% |
| September 30, 2024 | -$0.67 | — | +75.9% |
| June 30, 2024 | -$2.78 | — | -491.5% |
| March 31, 2024 | -$0.47 | — | -2250.0% |
| June 30, 2015 | -$0.02 | -100.0% | -100.0% |
| March 31, 2015 | -$0.01 | -133.3% | +0.0% |
- Zivo Bioscience, Inc. showed an increase of +8.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2024 period, Zivo Bioscience, Inc.’s diluted eps has grown by 8.0% (from $4.60 per share (loss) to $4.23 per share (loss)).
- The most recent figure is from Zivo Bioscience, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: